We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$77.4B
AUM Growth
-$2.68B
Cap. Flow
-$1.24B
Cap. Flow %
-1.6%
Top 10 Hldgs %
12.38%
Holding
4,070
New
663
Increased
931
Reduced
1,797
Closed
653

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$649M
2
NKE icon
Nike
NKE
+$453M
3
TSLA icon
Tesla
TSLA
+$431M
4
AZN icon
AstraZeneca
AZN
+$389M
5
KO icon
Coca-Cola
KO
+$336M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$897M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$578M
3
MRNA icon
Moderna
MRNA
+$438M
4
AAPL icon
Apple
AAPL
+$417M
5
AON icon
Aon
AON
+$386M

Sector Composition

Rank Sector Weight
1 Technology 20.4%
2 Healthcare 20.27%
3 Consumer Staples 11.15%
4 Consumer Discretionary 9.81%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEVL
3101
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$282K ﹤0.01%
9,600
-26,400
-73% -$728K
ONCR
3102
DELISTED
Oncorus, Inc.
ONCR
$281K ﹤0.01%
+30,071
New +$343K
NGM
3103
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$280K ﹤0.01%
+13,300
New +$293K
ACGN
3104
DELISTED
Aceragen Inc
ACGN
$280K ﹤0.01%
+15,995
New +$289K
CHNR icon
3105
China Natural Resources
CHNR
$5.13M
$279K ﹤0.01%
5,633
-2,625
-32% -$144K
ICD
3106
DELISTED
Independence Contract Drilling, Inc.
ICD
$279K ﹤0.01%
93,100
+7,900
+9% +$25.4K
AFIB
3107
DELISTED
Acutus Medical Inc
AFIB
$279K ﹤0.01%
+31,586
New +$416K
CPRX
3108
DELISTED
Catalyst Pharmaceutical
CPRX
$277K ﹤0.01%
+52,238
New +$286K
MOGU
3109
MOGU Inc
MOGU
$15.3M
$276K ﹤0.01%
23,700
-6,117
-21% -$86K
JP
3110
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
$275K ﹤0.01%
261,525
-61,300
-19% -$81.8K
DXR icon
3111
Daxor
DXR
$59.5M
$274K ﹤0.01%
23,421
-500
-2% -$5.09K
NYC
3112
American Strategic Investment Co
NYC
$24M
$274K ﹤0.01%
+4,238
New +$366K
RETO icon
3113
ReTo Eco-Solutions
RETO
$10.2M
$274K ﹤0.01%
2
-1
-33% -$182K
GROY icon
3114
Gold Royalty Corp
GROY
$732M
$270K ﹤0.01%
53,900
-11,800
-18% -$58.2K
NBR icon
3115
Nabors Industries
NBR
$1.33B
$270K ﹤0.01%
+2,800
New +$244K
CFBK icon
3116
CF Bankshares
CFBK
$235M
$268K ﹤0.01%
13,123
-1,377
-9% -$26.4K
ADMA icon
3117
ADMA Biologics
ADMA
$2.11B
$266K ﹤0.01%
235,000
+59,374
+34% +$83.2K
GTX icon
3118
Garrett Motion
GTX
$5.47B
$266K ﹤0.01%
36,100
-417,500
-92% -$3M
HUIZ
3119
Huize Holding Ltd
HUIZ
$13M
$266K ﹤0.01%
23,316
+3,576
+18% +$60.1K
MBII
3120
DELISTED
Marrone Bio Innovations, Inc.
MBII
$266K ﹤0.01%
295,500
+274,100
+1,281% +$330K
STAB
3121
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$264K ﹤0.01%
114,198
+16,147
+16% +$61.2K
KOPN icon
3122
Kopin
KOPN
$898M
$262K ﹤0.01%
+51,000
New +$310K
MAC icon
3123
Macerich
MAC
$6.99B
$262K ﹤0.01%
+15,700
New +$266K
RNDB
3124
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
$261K ﹤0.01%
12,092
-15,184
-56% -$313K
SUMR
3125
DELISTED
Summer Infant, Inc.
SUMR
$261K ﹤0.01%
30,223
-3,300
-10% -$33.7K
123 124
125
126 127

Similar funds

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Jim Simons's Q3 2021 Portfolio in Review

As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
  • Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
  • Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
  • Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
  • Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
  • Jim Simons opened 663 new positions and closed 653 in Q3 2021.
  • Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.

Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.